Ofer Zohar

Title: Ofer Zohar: Innovator in Neurotrauma Treatment

Introduction

Ofer Zohar is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of neurotrauma treatment, particularly through his innovative approaches to addressing memory impairment and brain injury resulting from head trauma.

Latest Patents

Zohar holds a patent titled "Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury." This invention outlines the use of protein kinase activators or boosters of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), or other neurotrophic factors to treat head trauma. Specifically, the patent describes methods for treating head trauma by identifying a subject who has suffered from such trauma and administering a pharmaceutical composition that includes a protein kinase C (PKC) activator or 4-methylcatechol acetic acid (MCBA) along with a pharmaceutically acceptable carrier. This innovative approach aims to alleviate at least one symptom of head trauma.

Career Highlights

Throughout his career, Zohar has worked with various organizations that focus on cognitive research and neuroscience. Notably, he has been associated with Cognitive Research Enterprises, Inc. and the Blanchette Rockefeller Neurosciences Institute. His work in these institutions has contributed to advancements in understanding and treating cognitive impairments.

Collaborations

Zohar has collaborated with esteemed professionals in his field, including Daniel L Alkon, enhancing the impact of his research and innovations.

Conclusion

Ofer Zohar's contributions to neurotrauma treatment through his patent and career in cognitive research highlight his commitment to improving the lives of individuals affected by head injuries. His innovative methods and collaborations continue to pave the way for advancements in this critical area of medicine.